TTOO News and Press, T2 Biosystems Inc. From 06/01/23

2023-06-01 08:17:13 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips QuantaSing (NASDAQ: QSG ) stock is on the rise Thursday following the release of the company’s earnings report for fiscal Q3 2023 . The good news for OSG stock st...

2023-06-01 08:01:50 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips T2 Biosystems (NASDAQ: TTOO ) stock is rising higher on Thursday after the company announced a new sale of instruments in Poland. According to a press release, this sale...

2023-05-31 06:00:00 ET 3 Reasons to Consider Buying Penny Stocks in 2023 As the financial world constantly evolves, savvy investors are always seeking dynamic strategies to diversify their portfolio. A promising avenue that has gained considerable attention in 2023 is the realm of pen...

2023-05-30 13:14:47 ET Gainers: Atento ( ATTO ) +92% . Wearable Devices ( WLDS ) +86% . T2 Biosystems ( TTOO ) +55% . Arlington Asset Investment ( AAIC ) +45% . Equitrans Midstream Corporation ( ETRN ) +36% . The Glimpse Grou...

2023-05-30 09:30:13 ET T2 Biosystems ( NASDAQ: TTOO ) stock price scales 31% with the second largest sale of sepsis-driven T2Dx instruments in company history. Its distribution partner, Biomedica Poland, secured a multi-year contract for T2Dx instruments and sepsis test ...

LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the second largest sale of sepsis-driven T2Dx® Instruments in Company history. T2 Bios...

2023-05-23 11:50:19 ET T2 Biosystems, Inc. (TTOO) Q1 2023 Earnings Conference Call May 23, 2023, 08:30 ET Company Participants Philip Taylor - Gilmartin Group John Sperzel - President, CEO & Chairman John Sprague - CFO Brett Giffin - Chief Commercial Offi...

2023-05-23 09:58:35 ET T2 Biosystems ( NASDAQ: TTOO ) lost ~28% in the morning hours Tuesday after the diagnostics company announced lower-than-expected Q1 2023 financials and disclosed a restructuring program amid plans to seek strategic alternatives. The Lexington, Massa...

2023-05-23 09:13:27 ET T2 Biosystems ( NASDAQ: TTOO ) said it submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its T2Biothreat panel to detect certain biothreat pathogens. The FDA filing follows a recently completed U.S. clinical evalu...

2023-05-23 08:13:48 ET T2 Biosystems press release ( NASDAQ: TTOO ): Q1 GAAP EPS of -$1.32 misses by $0.07 . Revenue of $2.1M (-71.0% Y/Y) misses by $0.23M . Shares +6% PM. The company reiterates its FY2023 financial outlook and continues to expect tota...